PanGen Biotech Inc. (KOSDAQ:222110)
South Korea
· Delayed Price · Currency is KRW 4,680.00
-100.00 (-2.09%)
Last updated: Mar 31, 2025
PanGen Biotech Revenue
In the year 2024, PanGen Biotech had annual revenue of 14.67B KRW with 100.58% growth. PanGen Biotech had revenue of 4.34B in the quarter ending December 31, 2024, with 28.03% growth.
Revenue
14.67B
Revenue Growth
+100.58%
P/S Ratio
3.62
Revenue / Employee
n/a
Employees
n/a
Market Cap
59.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 14.67B | 7.36B | 100.58% |
| Dec 31, 2023 | 7.32B | 814.47M | 12.53% |
| Dec 31, 2022 | 6.50B | -1.43B | -18.08% |
| Dec 31, 2021 | 7.94B | 1.74B | 28.18% |
| Dec 31, 2020 | 6.19B | 3.31B | 114.87% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 66.19T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 175.23T |
| Celltrion | 3,557.30B |
| Kia Corporation | 107.45T |
| KB Financial Group | 15.01T |